and diluted common share ($0.51) $0.41
========= =========
Weighted average common shares
outstanding - basic and diluted 50,902 49,160
========= =========
7/31/2024 7/31/2023
Selected balance sheet data: (unaudited) (unaudited)
----------------------------------- -------------- --------------
Cash and cash equivalents (includes
restricted cash of $1,000 at
7/31/23) $ 52,371 $ 83,373
Working capital 45,237 58,467
Stockholders' equity 56,112 78,462
Total assets 85,764 121,880
The following table presents a reconciliation of
reported net loss and basic and diluted net loss per
share to Adjusted net loss and Adjusted basic and
diluted net loss per share for the twelve months
ended July 31, 2024.
ENZO BIOCHEM, INC.
Non-GAAP Reconciliation Table
(Unaudited, in thousands, except per share data)
Twelve months ended
July 31,
-----------------------
2024
--------------
Reported GAAP loss $ (26,078)
Adjusted for:
Discrete legal matters 2,377
Fair value adjustment 1,095
Discrete separation expenses 1,742
Net loss from discontinued operations 16,261
Adjusted net loss $ (4,603)
=== ==============
Weighted Shares Outstanding:
Basic and diluted 50,902
Basic and diluted earnings per share:
Basic and diluted net loss per share GAAP ($0.51)
Basic and diluted net loss per share non-GAAP ($0.09)
The following table presents a reconciliation of
reported GAAP net loss for the twelve months
ended July 31, 2024 to EBITDA and Adjusted
EBITDA:
ENZO BIOCHEM, INC.
EBITDA & Adjusted EBITDA Reconciliation Table
(Unaudited, in thousands)
Twelve months ended
July 31,
-------------------------
2024
--------------
GAAP net loss $ (26,078)
Plus (minus):
Depreciation and amortization 1,272
Interest (income) expense, net (3,341)
Income tax benefit - discontinued operations (390)
EBITDA (28,537)
Adjusted for:
Discrete legal matters 2,377
Fair value adjustment 1,095
Discrete separation expenses 1,742
Net loss from discontinued operations before
income tax benefit 16,651
Foreign exchange loss 192
Adjusted EBITDA $ (6,480)
=== ==============
(END) Dow Jones Newswires
October 29, 2024 19:59 ET (23:59 GMT)
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。